Literature DB >> 27746464

Outcome of Both Bone Forearm Fracture Fixation in Children by Rush Nails.

R Dwivedi1, R Joshi1, S Panthi1, S Byanjankar1, R Shrestha1.   

Abstract

INTRODUCTION: Forearm fractures are common upper limb injuries among children and usually treated non-operatively. Failure of non-operative treatment, open injuries and multiple fractures are the indications for surgery in paediatric both bone forearm fractures. Intramedullary nailing is considered as minimally invasive procedure with excellent to fair outcomes but it is not free of complications. We reviewed the results and evaluated the outcomes of IM fixation of forearm fractures in children by Rush nails to understand the risks and complications associated with these procedures.
METHODS: A retrospective crossectional study of all paediatric patients treated for diaphyseal forearm fractures for period of five years in a tertiary care setup. Complications were classified according to modified Clavien-Dindo complication classification system. Outcomes were graded depending upon complication grade along with range of motion of forearm.
RESULTS: A total of 25 patients were included in the study. Mean time for fracture union was 10.56 weeks. Outcomes were excellent in 16 (64%), good in 7 (28%), fair in 2 (8%) patients and no poor outcome was noted. Ten minor complications were seen.
CONCLUSION: Fixation of paediatric forearm fractures by intramedullary Rush nail is minimally invasive procedure and outcomes are excellent to fair with acceptable complication rates.

Entities:  

Keywords:  complication; forearm fractures; intramedullary nailing; outcome; paediatrics; Rush nail.

Year:  2015        PMID: 27746464

Source DB:  PubMed          Journal:  JNMA J Nepal Med Assoc        ISSN: 0028-2715            Impact factor:   0.406


  1 in total

1.  Refracture of the Pediatric Forearm with Intramedullary Nails in situ.

Authors:  Cathleen J O'Neill; Eammon Fitzgerald; Ken Kaar; Colin G Murphy
Journal:  J Orthop Case Rep       Date:  2019
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.